Back to search

Article

58 risk and 34 protective effects of <i>GLP1R</i> on disease phenome and adverse neonatal health

2026-01-26

Abstract excerpt

Cardiometabolic gene-target drugs such as Glucagon-Like Peptide 1 Receptor agonists are used extensively, yet risks and repurposing have not been systematically evaluated across a comprehensive set of diseases. We use Phenome-wide Mendelian Randomization to test GLP1R gene expression and Cholesteryl Ester Transfer Protein (CETP) concentration, two promising cardiometabolic drug targets, on risk of 396 diseases ba...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e3f9a6ab-eecf-5590-ad64-be1fc8f59025
DOI
10.64898/2026.01.24.26344404
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
58 risk and 34 protective effects of <i>GLP1R</i> on disease phenome and adverse neonatal healthDOI 10.64898/2026.01.24.26344404
Select a neighboring publication to make it the new centre.